Microbot Medical begins pre-clinical trials for robot system; shares rise
12/09/2022 20:59
** Shares of medical device maker Microbot Medical MBOT.O
rise 11.1% to $6.10
** Co begins pre-clinical trials for its LIBERTY Robotic
System urn:newsml:reuters.com:*:nGNX3NG57F
** CEO Harel Gadot says co believes it will be able to meet
key goals in study, and progress towards regulatory approvals
** Liberty is the first ever fully disposable surgical robot
designed to streamline endovascular procedures, according to the
co's website
** More than 34,000 shares changed hands, 4 times the
stock's 25-day moving average volume
(Reporting by Nandhini Srinivasan in Bengaluru)
((Nandhini.srinivasan@thomsonreuters.com))
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones